Vimarsana
Biggest News Aggregation in the World

Guy Goodwin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guy Goodwin Today - Breaking & Trending Today

COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript - Vimarsana News

COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript

COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript February 29, 2024 COMPASS Pathways plc misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.37. COMPASS Pathways plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]

Source: yahoo.com
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript - Vimarsana News

Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript

CMPS earnings call for the period ending December 31, 2023.

Source: yahoo.com
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript - Vimarsana News

Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript

CMPS earnings call for the period ending December 31, 2023.

Source: fool.com
Preliminary Phase 2 Data Shows Psilocybin for PTSD Is Well-Tolerated - Vimarsana News

Preliminary Phase 2 Data Shows Psilocybin for PTSD Is Well-Tolerated

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

Compass Pathways Says Psilocybin PTSD Treatment Well Tolerated - Vimarsana News

Compass Pathways Says Psilocybin PTSD Treatment Well Tolerated

By Sabela Ojea Compass Pathways said early data from its post-traumatic stress disorder phase 2 clinical trial showed the psilocybin treatment was well...